1-4 of 4
Fiorenza Fruet
Close
Sort by
Journal Articles

Donor Natural Killer (NK) Alloreactivity Predicts Long-Term Relapse-Free Survival in Acute Myeloid Leukemia Patients Undergoing Immunotherapy with NK Cells

Antonio Curti, Loredana Ruggeri, Sarah Parisi, Andrea Bontadini, Elisa Dan, Simonetta Rizzi, Maria Rosa Motta, Sara Trabanelli, Darina Ocadlikova, Mariangela Lecciso, Valeria Giudice, Elena Urbani, Cristina Papayannidis, Giovanni Martinelli, Francesca Bonifazi, Giuseppe Bandini, Fiorenza Fruet, Russel E. Lewis, Michele Cavo, Andrea Velardi, Roberto M. Lemoli
Journal: Blood
Blood (2014) 124 (21): 624.
https://doi.org/10.1182/blood.V124.21.624.624
Published: 2014
Journal Articles

Successful transfer of alloreactive haploidentical KIR ligand-mismatched natural killer cells after infusion in elderly high risk acute myeloid leukemia patients

Antonio Curti, Loredana Ruggeri, Alessandra D'Addio, Andrea Bontadini, Elisa Dan, Maria Rosa Motta, Sara Trabanelli, Valeria Giudice, Elena Urbani, Giovanni Martinelli, Stefania Paolini, Fiorenza Fruet, Alessandro Isidori, Sarah Parisi, Giuseppe Bandini, Michele Baccarani, Andrea Velardi, Roberto M. Lemoli
Journal: Blood
Blood (2011) 118 (12): 3273–3279.
https://doi.org/10.1182/blood-2011-01-329508
Published: 2011
Includes: Supplemental data
Journal Articles

Adoptive Immunotherapy with Haploidentical Kir Ligand-Mismatched Natural Killer Cells In Elderly High Risk Acute Myeloid Leukemia Patients: Biological and Clinical Results of A Pilot Study

Antonio Curti, PhD, Loredana Ruggeri, PhD, Alessandra D'Addio, Andrea Bontadini, PhD, Valeria Giudice, PhD, Elisa Dan, PhD, Maria Rosa Motta, PhD, Simonetta Rizzi, Sara Trabanelli, PhD, Elena Urbani, PhD, Giovanni Martinelli, PhD, Stefania Paolini, PhD, Fiorenza Fruet, PhD, Alessandro Isidori, Beatrice Casadei, PhD, Giuseppe Bandini, PhD, Michele Baccarani, PhD, Andrea Velardi, PhD, Roberto M. Lemoli
Journal: Blood
Blood (2010) 116 (21): 4287.
https://doi.org/10.1182/blood.V116.21.4287.4287
Published: 2010
Journal Articles

Phase I-II Trial of Adoptive Immunotherapy with Haploidentical KIR Ligand-Mismatched Natural Killer Cells in High Risk Acute Myeloblastic Leukemia Patients.

Antonio Curti, MD, Loredana Ruggeri, BS, Alessandra D’Addio, MD, Elena Urbani, BS, Andrea Bontadini, MD, Fiorenza Fruet, BS, Valeria Giudice, MD, Elisa Dan, BS, Maria Rosa Motta, BS, Simona Rizzi, BS, Stefania Paolini, MD, Gabriele Gugliotta, MD, Roberto Conte, MD, Giovanni Martinelli, MD, Andrea Velardi, MD, Michele Baccarani, MD, Roberto M. Lemoli, MD
Journal: Blood
Blood (2007) 110 (11): 2857.
https://doi.org/10.1182/blood.V110.11.2857.2857
Published: 2007